Can BCG be useful to mitigate the COVID-19 pandemic? A Canadian perspective

There is ample evidence from in vitro, animal and human studies that the Bacillus Calmette-Guerin (BCG) vaccine epigenetically reprograms innate immunity to provide “off target” protection against pathogens other than mycobacteria. This process has been termed “trained immunity”. Although recent eco...

Descripción completa

Detalles Bibliográficos
Autores principales: De Wals, Philippe, Menzies, Dick, Divangahi, Maziar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Special Section on COVID-19: Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676406/
https://www.ncbi.nlm.nih.gov/pubmed/33211246
http://dx.doi.org/10.17269/s41997-020-00439-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676406/
https://www.ncbi.nlm.nih.gov/pubmed/33211246
http://dx.doi.org/10.17269/s41997-020-00439-7

Ejemplares similares